Annexin A9 promotes invasion and metastasis of colorectal cancer and predicts poor prognosis

Yu,Suyang; Bian,Honglei; Gao,Xin; Gui,Lin

doi:10.3892/ijmm.2018.3432

Annexin A9 promotes invasion and metastasis of colorectal cancer and predicts poor prognosis

Authors:
- Suyang Yu
- Honglei Bian
- Xin Gao
- Lin Gui
View Affiliations

Affiliations: First Department of Colorectal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, ICU of Department of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China
Published online on: January 29, 2018 https://doi.org/10.3892/ijmm.2018.3432
Pages: 2185-2192

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Annexin A9 (ANXA9), a member of annexin family, has been reported be associated with colorectal cancer (CRC) carcinogenesis. However, the clinical significance of ANXA9 in CRC, particularly its correlation to invasion and metastasis remains ambiguous. The aim of the present study was to investigate the significance of ANXA9 in CRC and understand the molecular mechanism of ANXA9 in CRC invasion and metastasis. Expression levels of the ANXA9 protein in CRC tissues were detected using immunohistochemistry (IHC), and the clinical and prognostic value of ANXA9 was investigated. ANXA9‑siRNA was utilized to investigate the effect and molecular mechanism of ANXA9 in HCT116 cells. The IHC result demonstrated that the positivity rate of the ANXA9 protein in CRC tissue was significantly higher than that in adjacent mucosa (P<0.05), which was consistent with the western blot results. ANXA9 protein expression levels are associated with invasion depth and lymphatic metastasis. Furthermore, patients with ANXA9‑positive expression demonstrated a poor prognosis and ANXA9 was an independent risk factor for survival (P<0.05). After inhibiting ANXA9 in HCT116 cells, the activity and metastatic and invasion capacity of cells decreased significantly, and expression levels of ADAM metallopeptidase domain 17 and matrix metallopeptidase 9 were significantly downregulated, while the expression levels of tissue inhibitors of metalloproteinases‑1 and E‑cadherin were upregulated (P<0.05). Thus, positive ANXA9 expression may present as a novel marker for predicting poor prognosis in CRC patients, and ANXA9 may promote the invasion and metastasis of CRC by regulating invasion and metastasis‑associated genes.

View Figures

View References

1	Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP and Kuipers EJ: Colorectal cancer screening: A global overview of existing programmes. Gut. 64:1637–1649. 2015. View Article : Google Scholar : PubMed/NCBI
2	Mol L, Ottevanger PB, Koopman M and Punt CJ: The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients. Eur J Cancer. 66:138–143. 2016. View Article : Google Scholar : PubMed/NCBI
3	van Wyk HC, Roxburgh CS, Horgan PG, Foulis AF and McMillan DC: The detection and role of lymphatic and blood vessel invasion in predicting survival in pa'tients with node negative operable primary colorectal cancer. Crit Rev Oncol Hematol. 90:77–90. 2014. View Article : Google Scholar
4	Ning Y and Lenz HJ: Targeting IL-8 in colorectal cancer. Expert Opin Ther Targets. 16:491–497. 2012. View Article : Google Scholar : PubMed/NCBI
5	Wu M, Wang J, Tang W, Zhan X, Li Y, Peng Y, Huang X, Bai Y, Zhao J, Li A, et al: FOXK1 interaction with FHL2 promotes proliferation, invasion and metastasis in colorectal cancer. Oncogenesis. 5:e2712016. View Article : Google Scholar : PubMed/NCBI
6	Jeong SH, Jeon YJ and Park SJ: Inhibitory effects of dieckol on hypoxia-induced epithelial-mesenchymal transition of HT29 human colorectal cancer cells. Mol Med Rep. 14:5148–5154. 2016. View Article : Google Scholar : PubMed/NCBI
7	Kim BR, Kang MH, Kim JL, Na YJ, Park SH, Lee SI, Kang S, Joung SY, Lee SY, Lee DH, et al: RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer. Oncol Rep. 36:2601–2608. 2016. View Article : Google Scholar : PubMed/NCBI
8	Shi W, Ye Z, Zhuang L, Li Y, Shuai W, Zuo Z, Mao X, Liu R, Wu J, Chen S and Huang W: Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells. J Pathol. 240:352–365. 2016. View Article : Google Scholar : PubMed/NCBI
9	Boudhraa Z, Bouchon B, Viallard C, D'Incan M and Degoul F: Annexin A1 localization and its relevance to cancer. Clin Sci. 130:205–220. 2016. View Article : Google Scholar : PubMed/NCBI
10	Qi H, Liu S, Guo C, Wang J, Greenaway FT and Sun MZ: Role of Annexin A6 in cancer. Oncol Lett. 10:1947–1952. 2015. View Article : Google Scholar : PubMed/NCBI
11	Lauritzen SP, Boye TL and Nylandsted J: Annexins are instrumental for efficient plasma membrane repair in cancer cells. Semin Cell Dev Biol. 45:32–38. 2015. View Article : Google Scholar : PubMed/NCBI
12	Miyoshi N, Yamamoto H, Mimori K, Yamashita S, Miyazaki S, Nakagawa S, Ishii H, Noura S, Ohue M, Yano M, et al: ANXA9 gene expression in colorectal cancer: A novel marker for prognosis. Oncol Lett. 8:2313–2317. 2014. View Article : Google Scholar : PubMed/NCBI
13	Edge SB and Compton CC: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
14	Bode AM, Dong Z and Wang H: Cancer prevention and control: Alarming challenges in China. Natl Sci Rev. 3:117–127. 2016. View Article : Google Scholar : PubMed/NCBI
15	Liu J, Zhou Q, Xu J, Wang J and Zhang Y: Detection of EGFR expression in patients with colorectal cancer and the therapeutic effect of cetuximab. J BUON. 21:95–100. 2016.PubMed/NCBI
16	Bhopal RS: Diet and colorectal cancer incidence. JAMA Intern Med. 175:1726–1727. 2015. View Article : Google Scholar : PubMed/NCBI
17	Marley AR and Nan H: Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet. 7:105–114. 2016.PubMed/NCBI
18	Cai Z, Han S, Li Z, He L, Zhou J, Huang W and Xu Y: A genome-wide assessment of variations of primary colorectal cancer maintained in metastases. Gene. 595:18–24. 2016. View Article : Google Scholar : PubMed/NCBI
19	Wang H, Xi Q and Wu G: Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway. Cancer Med. 5:1599–1606. 2016. View Article : Google Scholar : PubMed/NCBI
20	Zou F, Mao R, Yang L, Lin S, Lei K, Zheng Y, Ding Y, Zhang P, Cai G, Liang X and Liu J: Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer. FEBS J. 283:1438–1452. 2016. View Article : Google Scholar : PubMed/NCBI
21	Zhang Z, Huang L, Zhao W and Rigas B: Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: Anticancer effects in vitro and in vivo. Cancer Res. 70:2379–2388. 2010. View Article : Google Scholar : PubMed/NCBI
22	Yang T, Peng H, Wang J, Yang J, Nice EC, Xie K and Huang C: Prognostic and diagnostic significance of Annexin A2 in colorectal cancer. Colorectal Dis. 15:e373–e381. 2013. View Article : Google Scholar : PubMed/NCBI
23	Boczonadi V and Määttä A: Annexin A9 is a periplakin interacting partner in membrane-targeted cytoskeletal linker protein complexes. FEBS Lett. 586:3090–3096. 2012. View Article : Google Scholar : PubMed/NCBI
24	Goebeler V, Ruhe D, Gerke V and Rescher U: Atypical properties displayed by annexin A9, a novel member of the annexin family of Ca²⁺ and lipid binding proteins. FEBS Lett. 546:359–364. 2003. View Article : Google Scholar : PubMed/NCBI
25	Blanchot-Jossic F, Jarry A, Masson D, Bach-Ngohou K, Paineau J, Denis MG, Laboisse CL and Mosnier JF: Up-regulated expression of ADAM17 in human colon carcinoma: Co-expression with EGFR in neoplastic and endothelial cells. J Pathol. 207:156–163. 2005. View Article : Google Scholar : PubMed/NCBI
26	Das S, Czarnek M, Bzowska M, Mężyk-Kopeć R, Stalińska K, Wyroba B, Sroka J, Jucha J, Deneka D, Stokłosa P, et al: ADAM17 silencing in mouse colon carcinoma cells: The effect on tumoricidal cytokines and angiogenesis. PLoS One. 7:e507912012. View Article : Google Scholar : PubMed/NCBI
27	Lima AI, Mota J, Monteiro SA and Ferreira RM: Legume seeds and colorectal cancer revisited: Protease inhibitors reduce MMP-9 activity and colon cancer cell migration. Food Chem. 197:30–38. 2016. View Article : Google Scholar
28	Liu F, Zhang T, Zou S, Jiang B and Hua D: B7-H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer. Mol Med Rep. 12:5455–5460. 2015. View Article : Google Scholar : PubMed/NCBI
29	Weidle UH, Birzele F and Krüger A: Molecular targets and pathways involved in liver metastasis of colorectal cancer. Clin Exp Metastasis. 32:623–635. 2015. View Article : Google Scholar : PubMed/NCBI
30	Christensen IJ, Brünner N, Dowell B, Davis G, Nielsen HJ, Newstead G and King D: Plasma TIMP-1 and CEA as markers for detection of primary colorectal cancer: A prospective validation study including symptomatic and non-symptomatic individuals. Anticancer Res. 35:4935–4941. 2015.PubMed/NCBI
31	Nakayama H, Fukuda S, Inoue H, Nishida-Fukuda H, Shirakata Y, Hashimoto K and Higashiyama S: Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin. Mol Biol Cell. 23:1964–1975. 2012. View Article : Google Scholar : PubMed/NCBI
32	Xiao LJ, Lin P, Lin F, Liu X, Qin W, Zou HF, Guo L, Liu W, Wang SJ and Yu XG: ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Int J Oncol. 40:1714–1724. 2012.
33	Li Q, Wang Y, Lai Y, Xu P and Yang Z: HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling. PLoS One. 12:e01825882017. View Article : Google Scholar : PubMed/NCBI
34	Iseki Y, Shibutani M, Maeda K, Nagahara H, Ikeya T and Hirakawa K: Significance of E-cadherin and CD44 expression in patients with unresectble metastatic colorectal cancer. Oncol Lett. 14:1025–1034. 2017. View Article : Google Scholar : PubMed/NCBI
35	Yan X, Yan L, Liu S, Shan Z, Tian Y and Jin Z: N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer. Mol Med Rep. 12:2999–3006. 2015. View Article : Google Scholar : PubMed/NCBI